hypericin has been researched along with Colorectal Cancer in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study evaluates the efficacy of Hypericin-PDT as a cytotoxic therapy in colorectal cancer (CRC), using 2D cell cultures and 3D multicellular tumour spheroids." | 7.88 | Inhibiting ABCG2 could potentially enhance the efficacy of hypericin-mediated photodynamic therapy in spheroidal cell models of colorectal cancer. ( Andrew, H; Armstrong, G; Hughes, TA; Jayne, DG; Kapur, N; Khot, MI; Maisey, T; Perry, SL, 2018) |
| "Hypericin is a powerful photosensitizer with pronounced tumor-localizing properties." | 5.62 | Hypericin-mediated photodynamic therapy inhibits growth of colorectal cancer cells via inducing S phase cell cycle arrest and apoptosis. ( Chen, L; Hu, J; Song, J; Tang, Z; Wei, S; Zhou, R, 2021) |
| "Hypericin is a well-studied photosensitizer." | 5.43 | Enhancement of oxaliplatin sensitivity in human colorectal cancer by hypericin mediated photodynamic therapy via ROS-related mechanism. ( Du, W; Gao, Y; Lei, K; Liang, X; Lin, S; Liu, J; Shi, H; Yang, L; Yin, P, 2016) |
| "Photodynamic therapy with hypericin (HY-PDT) and hyperforin (HP) could be treatment modalities for colorectal cancer (CRC), but evidence of their effect on angiogenic factors in CRC is missing." | 3.91 | Novel Insights into the Effect of Hyperforin and Photodynamic Therapy with Hypericin on Chosen Angiogenic Factors in Colorectal Micro-Tumors Created on Chorioallantoic Membrane. ( Babinčák, M; Buríková, M; Fedoročko, P; Jendželovská, Z; Jendželovský, R; Košuth, J; Majerník, M; Ševc, J; Tonelli Gombalová, Z, 2019) |
| " This study evaluates the efficacy of Hypericin-PDT as a cytotoxic therapy in colorectal cancer (CRC), using 2D cell cultures and 3D multicellular tumour spheroids." | 3.88 | Inhibiting ABCG2 could potentially enhance the efficacy of hypericin-mediated photodynamic therapy in spheroidal cell models of colorectal cancer. ( Andrew, H; Armstrong, G; Hughes, TA; Jayne, DG; Kapur, N; Khot, MI; Maisey, T; Perry, SL, 2018) |
| "Hypericin is a powerful photosensitizer with pronounced tumor-localizing properties." | 1.62 | Hypericin-mediated photodynamic therapy inhibits growth of colorectal cancer cells via inducing S phase cell cycle arrest and apoptosis. ( Chen, L; Hu, J; Song, J; Tang, Z; Wei, S; Zhou, R, 2021) |
| "Hypericin is a well-studied photosensitizer." | 1.43 | Enhancement of oxaliplatin sensitivity in human colorectal cancer by hypericin mediated photodynamic therapy via ROS-related mechanism. ( Du, W; Gao, Y; Lei, K; Liang, X; Lin, S; Liu, J; Shi, H; Yang, L; Yin, P, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Macejová, M | 1 |
| Sačková, V | 1 |
| Hradická, P | 1 |
| Jendželovský, R | 3 |
| Demečková, V | 1 |
| Fedoročko, P | 3 |
| Sardoiwala, MN | 1 |
| Kushwaha, AC | 1 |
| Dev, A | 1 |
| Shrimali, N | 1 |
| Guchhait, P | 1 |
| Karmakar, S | 1 |
| Roy Choudhury, S | 1 |
| Hu, J | 1 |
| Song, J | 1 |
| Tang, Z | 1 |
| Wei, S | 1 |
| Chen, L | 1 |
| Zhou, R | 1 |
| Khot, MI | 1 |
| Perry, SL | 1 |
| Maisey, T | 1 |
| Armstrong, G | 1 |
| Andrew, H | 1 |
| Hughes, TA | 1 |
| Kapur, N | 1 |
| Jayne, DG | 1 |
| Majerník, M | 1 |
| Babinčák, M | 1 |
| Košuth, J | 1 |
| Ševc, J | 1 |
| Tonelli Gombalová, Z | 1 |
| Jendželovská, Z | 1 |
| Buríková, M | 1 |
| Lin, S | 1 |
| Lei, K | 1 |
| Du, W | 1 |
| Yang, L | 1 |
| Shi, H | 1 |
| Gao, Y | 1 |
| Yin, P | 1 |
| Liang, X | 1 |
| Liu, J | 1 |
| Gyurászová, K | 1 |
| Mikeš, J | 1 |
| Halaburková, A | 1 |
7 other studies available for hypericin and Colorectal Cancer
| Article | Year |
|---|---|
Combination of photoactive hypericin and Manumycin A exerts multiple anticancer effects on oxaliplatin-resistant colorectal cells.
Topics: Anthracenes; Antineoplastic Agents; Apoptosis Regulatory Proteins; Cell Line; Cell Proliferation; Ce | 2020 |
Hypericin-Loaded Transferrin Nanoparticles Induce PP2A-Regulated BMI1 Degradation in Colorectal Cancer-Specific Chemo-Photodynamic Therapy.
Topics: Anthracenes; Colorectal Neoplasms; Humans; Nanoparticles; Perylene; Photochemotherapy; Tissue Distri | 2020 |
Hypericin-mediated photodynamic therapy inhibits growth of colorectal cancer cells via inducing S phase cell cycle arrest and apoptosis.
Topics: Anthracenes; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Prolifer | 2021 |
Inhibiting ABCG2 could potentially enhance the efficacy of hypericin-mediated photodynamic therapy in spheroidal cell models of colorectal cancer.
Topics: Anthracenes; Apoptosis; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Survival; Colo | 2018 |
Novel Insights into the Effect of Hyperforin and Photodynamic Therapy with Hypericin on Chosen Angiogenic Factors in Colorectal Micro-Tumors Created on Chorioallantoic Membrane.
Topics: Angiogenesis Inducing Agents; Animals; Anthracenes; Biomarkers; Cell Line, Tumor; Chick Embryo; Chor | 2019 |
Enhancement of oxaliplatin sensitivity in human colorectal cancer by hypericin mediated photodynamic therapy via ROS-related mechanism.
Topics: Anthracenes; Apoptosis; Colorectal Neoplasms; DNA Damage; DNA Repair; Drug Resistance, Neoplasm; Dru | 2016 |
YM155, a small molecule inhibitor of survivin expression, sensitizes cancer cells to hypericin-mediated photodynamic therapy.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Anthracenes; Antineoplastic Agents; Autophagy; Caspase 3; Ce | 2016 |